# A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects

> **NCT03235375** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 37 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** MEDI0382

## Key facts

- **NCT ID:** NCT03235375
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-27
- **Primary completion:** 2018-04-24
- **Final completion:** 2018-04-24
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235375, "A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03235375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*